Infectious disease
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Pfizer and BioNTech updated their development program, with plans to launch clinical trials in the U.S. and Europe across multiple sites by the end of April.
The world continues to wait with bated breath for a treatment for COVID-19, and Pluristem Therapeutics appears to be on the cusp of providing some hope.
Although the data hasn’t been released yet, analysts are making predictions based on what little they do know.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 9, 2020.
The fastest way to get a safe, effective vaccine for COVID-19 to physicians and patients is to build upon an existing vaccine with an already-established manufacturing and supply chain…or to revolutionize the manufacturing process.
AstraZeneca made an announcement describing its internal and partnering efforts to battle COVID-19, the disease caused by the novel coronavirus SARS-CoV-2.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.
As the pandemic progresses, researchers are attacking the virus from every angle, and also learning more and more about how and why the virus affects who it does.
The United States leads the world in biotech innovation, but does it also lead the world in the development of COVID-19 diagnostics, vaccines and therapeutics?
PRESS RELEASES